In most HIV-infected individuals adherent to modern antiretroviral therapy (ART), plasma
viremia stays undetectable by clinical assays and therefore, additional virological markers …

Abstract Purpose of Review Despite the success of antiretroviral therapy in suppressing HIV,
life-long therapy is required to avoid HIV reactivation from long-lived viral reservoirs …

Combination antiretroviral therapy (cART) suppresses viral replication but does not cure HIV
infection because a reservoir of infectious (intact) HIV proviruses persists in long-lived CD4+ …

Torquetenovirus (TTV) is the most abundant component of the human blood virome and its
replication is controlled by a functioning immune system. In this study, TTV replication was …

The focus of this review is to examine the importance of quantifying total HIV DNA to target
the HIV reservoir and the clinical implications and challenges involved in its future …

Myeloid-derived suppressor cells (MDSC) are expanded during HIV-1 infection and
correlated with disease progression. MDSC expand in the early phase of primary infection …

Effective antiretroviral therapy usually leads to undetectable HIV-1 RNA in the plasma.
However, the virus persists in some cells of infected patients as various DNA forms, both …

Therapeutic vaccinations using human immunodeficiency virus (HIV) antigens in HIV-
infected patients on antiretroviral therapy (ART) have so far been attempted with the purpose …

UDPS combined with genotypic algorithms for prediction of HIV‐1 co‐receptor usage may
provide quantitative data about the tropism of each variant present in the viral quasispecies …

New methods of HIV-1 RNA quantification based on dual-target detection are increasingly
used in HIV viral load monitoring, but clinical implications and impact of dual-target detection …